1. Wei, Hua, Li, Yan, Du, Yaowu, Ma, Ji. 2018. KCND2 upregulation might be an independent indicator of poor survival in gastric cancer. In Future oncology (London, England), 14, 2811-2820. doi:10.2217/fon-2018-0418. https://pubmed.ncbi.nlm.nih.gov/30051729/
2. Zhang, Yongqiang, Tachtsidis, Georgios, Schob, Claudia, Kindler, Stefan, Bähring, Robert. . KCND2 variants associated with global developmental delay differentially impair Kv4.2 channel gating. In Human molecular genetics, 30, 2300-2314. doi:10.1093/hmg/ddab192. https://pubmed.ncbi.nlm.nih.gov/34245260/
3. Liu, Zehui, Yang, Xiaolei, Guo, Peiwen, Zou, Mingyang, Sun, Caihong. 2023. The association between gene polymorphisms in voltage-gated potassium channels Kv2.1 and Kv4.2 and susceptibility to autism spectrum disorder. In Frontiers in psychiatry, 13, 994166. doi:10.3389/fpsyt.2022.994166. https://pubmed.ncbi.nlm.nih.gov/36756634/
4. Yang, Shengjie, Zhou, Pengpeng, Qi, Lu, Li, Yang, Wang, Xinghe. 2023. Promoting proliferation and tumorigenesis of breast cancer: KCND2's significance as a prognostic factor. In Functional & integrative genomics, 23, 257. doi:10.1007/s10142-023-01183-0. https://pubmed.ncbi.nlm.nih.gov/37522982/
5. Lei, Guang-Lin, Li, Zhi, Li, Yuan-Yuan, Yang, Peng-Hui, Yang, Zhan-Yu. 2021. Long noncoding RNA FAM66C promotes tumor progression and glycolysis in intrahepatic cholangiocarcinoma by regulating hsa-miR-23b-3p/KCND2 axis. In Environmental toxicology, 36, 2322-2332. doi:10.1002/tox.23346. https://pubmed.ncbi.nlm.nih.gov/34418280/